IL13 and COVID-19: Moreover, COVID‐19 ARDS is associated with proinflammatory lipid mediators including prostaglandin D2 (PGD2) (Archambault et al., 2021), which produces IL‐13 and is associated with respiratory failure (Ogletree et al., 2022).